These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 11734662

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ, Meunier AM.
    Thromb Haemost; 1990 Nov 30; 64(3):455-63. PubMed ID: 2128976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots.
    Chernysh IN, Everbach CE, Purohit PK, Weisel JW.
    J Thromb Haemost; 2015 Apr 30; 13(4):601-9. PubMed ID: 25619618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
    Kajimoto Y, Ohta T, Kuroiwa T.
    Neurosurgery; 1997 Mar 30; 40(3):572-7. PubMed ID: 9055298
    [Abstract] [Full Text] [Related]

  • 10. Polyphosphate enhances fibrin clot structure.
    Smith SA, Morrissey JH.
    Blood; 2008 Oct 01; 112(7):2810-6. PubMed ID: 18544683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME.
    J Biol Chem; 1998 Oct 16; 273(42):27176-81. PubMed ID: 9765237
    [Abstract] [Full Text] [Related]

  • 14. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP, Lami D, Magi A, Liotta AA, Rogolino A, Antonucci E, Bandinelli B, Abbate R, Prisco D.
    Clin Appl Thromb Hemost; 2010 Jun 16; 16(3):337-44. PubMed ID: 19117964
    [Abstract] [Full Text] [Related]

  • 15. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N, Iwamoto M, Abiko Y.
    Thromb Res; 1987 Aug 15; 47(4):459-68. PubMed ID: 2821651
    [Abstract] [Full Text] [Related]

  • 16. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A, Shizume K, Cho M, Takada Y.
    Thromb Res; 1987 Feb 15; 45(4):371-81. PubMed ID: 2437668
    [Abstract] [Full Text] [Related]

  • 17. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
    Carr ME, Carr SL, Merten SR.
    Haemostasis; 1995 Feb 15; 25(4):172-81. PubMed ID: 7557656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
    Bauer R, Hansen SL, Jones G, Suenson E, Thorsen S, Ogendal L.
    Eur Biophys J; 1994 Feb 15; 23(4):239-52. PubMed ID: 7805626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.